Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.800
-0.120 (-6.25%)
At close: May 18, 2026, 4:00 PM EDT
1.770
-0.030 (-1.67%)
After-hours: May 18, 2026, 7:25 PM EDT

Acurx Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9.257.563.717.479.1112.96
Cash & Short-Term Investments
9.257.563.717.479.1112.96
Cash Growth
99.29%103.85%-50.41%-17.97%-29.69%308.10%
Other Receivables
0.060.050.050.13--
Total Trade Receivables
0.060.050.050.13--
Other Current Assets
0.230.090.10.110.260.3
Total Current Assets
9.547.693.867.719.3813.25
Total Assets
9.547.693.867.719.3813.25
Accounts Payable
2.532.423.243.042.060.84
Total Current Liabilities
2.532.423.243.042.060.84
Total Liabilities
2.532.423.243.042.060.84
Common Stock
---0.010.010.01
Additional Paid-in Capital
83.9880.5567.9457.8745.9438.95
Retained Earnings
-76.97-75.29-67.32-53.22-38.64-26.55
Shareholders' Equity
7.015.270.624.677.3212.41
Total Liabilities & Equity
9.547.693.867.719.3813.25
Net Cash (Debt)
9.257.563.717.479.1112.96
Net Cash Growth
22.48%103.85%-50.41%-17.97%-29.69%316.83%
Net Cash Per Share
4.815.044.5911.8016.8530.36
Book Value
7.015.270.624.677.3212.41
Book Value Per Share
3.643.520.767.3713.5329.08
Tangible Book Value
7.015.270.624.677.3212.41
Tangible Book Value Per Share
3.643.520.767.3713.5329.08
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q